Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Executive Vice President, Technical Operations
Bellicum Pharmaceuticals
Vice President Regulatory Affairs and Quality Assurance
Gyroscope Therapeutics
Senior Process Scientist
Gyroscope Therapeutics
Head of Cell Culture Media
Boehringer Ingelheim Corporate Center GmbH
Head of Business Development & Partnering
Genethon
Senior Director, EU Section & Public Policy
Alliance for Regeneratice Medicine
Vice President of Regenerative Medicine, Head of Cardiopulmonary Programs
Athersys
Vice President, Global Medical Affairs
Sarepta Therapeutics
Senior Scientist, Oncology Safety Combinations
AstraZeneca
Director Market Access EU North
PTC Therapeutics
Principal Scientist - Process Sciences
Ichnos Sciences SA
Chief Scientific and Technological Officer
Bone Therapeutics
Vice President Process Development
Evox Therapeutics
Chief Executive Officer
Orchard Therapeutics
Senior R&D Scientist, Biopharmaceutical Expression Systems Team
Merck KGaA
Scientific leader, Cell & Gene Therapy Platform CMC
GlaxoSmithKline
Vice President, Cell ular Engineering
Kite, A Gilead Company
Chief Medical Officer
Precision BioSciences
Associate Fellow, Investigator Disruptive Technologies
GlaxoSmithKline
Professor of Bioprocess Engineering
University of Sheffield
Director, Global Supply Chain
Kite Pharma
Group Leader: Development Scientist (DSP)
Adaptimmune
Senior Director
Orchard Therapeutics
Professor of Stem Cell Science
King's College London
Lead Translational Scientist
UCL Institute of Child Health
Associate Director, Immune Receptor Discovery
AgenTus Therapeutics
Executive Director of Regenerative Medicine
Astellas
Chief Scientific Officer
Spark Therapeutics
Associate Professor of Developmental Biology
University of Oxford
Operational Excellence Director - Region Europe
Takeda
Chief Executive Officer
Aivita Biomedical
Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affairs
Novartis
President of Research & Development
Century Therapeutics
Head of Data & Innovations, Global Commercial Innovation
AstraZeneca
Corporate Vice President
Novo Nordisk
Vice President, Venture Investments
Bayer
Senior Quality Assessor, Biological/Biotechnology Unit
MHRA
Director, Cell Culture Development
Boehringer Ingelheim Corporate Center GmbH
Senior Scientist - Cell & Gene Therapy
GammaDelta Tx
Senior Director, Head of Cell Therapy Clinical Pharmacology
Kite, A Gilead Company
Assistant Director, Cell Line Development
Genmab
Senior Downstream Process and Technical Transfer Expert Manufacturing Science and Technology
Novartis
Global Head of Cell Banking
AstraZeneca
Senior Director of Gene Therapy manufacturing
Biomarin
Chief Technical Officer
Mustang Bio
Associate Director of Vector Production
Voyager Therapeutics
Senior Scientist, R&D
Celyad
Head of Upstream Process Development
Novartis
Senior Principal Scientist
Pfizer
Head of Biotherapeutics Development & Drug Supply
Cancer Research UK 
Vice President
Pluristem
Scientific Director & Fellow, Functional Genomics
GlaxoSmithKline
Head of Molecular & Cellular Biology
MRC Harwell
Vice President
Instituto de Biologia Experimental e Tecnologica
Research Director
Plasticell
Manager, Cell Line Development, Cell and Gene Therapy Product Development
GlaxoSmithKline
Director
Genzyme
Senior Scientist
Spark Therapeutics
Vice President, Process Development
REGENXBIO
Chief Operations Officer
TreeFrog Therapeutics
Director/Fellow
AstraZeneca
Associate Professor and Group Leader
Inserm
Vice Presdient and Head of Clinical Research & Development
bluebird bio
Scientist, Perfusion / Cell Culture Media
Merck KGaA
Principal Scientist - Gene Therapy
Sanofi
Professor of Stem Cell Biology
Keele University
Senior Director, Health Economics & Outcomes Research
uniQure
Vice President, Cell & Gene Therapy
Orchard Therapeutics
Senior Vice President, Technical Operations
Sarepta Therapeutics
Director GMP for Immunotherapy
Children's National Medical Center
Director, Senior Global Regulatory Lead, Gene Therapies
CSL Behring
Senior Vice President
FerGene
Vice President, R&D Translational Medicine
AveXis, A Novartis Company
Site Head, Cell Therapy Technology Center
Takeda
Associate Professor
UCL
Senior Scientist, Lead of Non-Viral Vector Delivery Project
Kite, A Gilead Company
Group Leader
Kymab
Senior Vice President and Global Head of Research and Early Clinical Development, Cardiovascular, Renal and Metabolic Diseases
AstraZeneca
Associate Principal Scientist
AstraZeneca
Group Head CLD1
Novartis
Director
Bristol-Myers Squibb
Chief Executive Officer
International Serum Industry Association (ISIA)
Chief Medical Officer
Triumvira Immunologics
Professor of Biomedical Engineering
Georgia Institute of Technology
Executive Director
Biogen
QC Manager
Celyad
Principal Scientist
Boehringer Ingelheim Corporate Center GmbH
CMC Team Leader
Novartis
Head of CMC
Immunicum
Senior Vice President, Clinical Operations
Achilles Therapeutics
Group Leader Molecular & Cell Line Development
F. Hoffmann-La Roche Ltd
Senior Technical Product Steward for Kymriah
Novartis
Associate Director, Upstream Development
Boehringer Ingelheim Corporate Center GmbH
Professor of Cell Technology
Durham University
Chief Scientific Officer
iSTEM Therapeutics
Vice President, Head of Biotech Sciences
UCB PHARMA SA
Vice President and Head, Clinical Strategy, Regenerative Medicine
Takeda
Senior Scientist
bluebird bio
Senior Research Scientist
AstraZeneca
Senior Director
Cellectis
Vice President, Product Research & Development
Sanofi
Head of Launch Preparation and Coordination
Bayer AG
Global Head Drug Substance Development, Operational Sciences Mammalian
Novartis
Lead Monoclonal Antibodies Platform, Senior Manager
GlaxoSmithKline
Chief Financial Officer
Legend Biotech
Head of Cell Therapy Development Operations
Juno Therapeutics
Principal Engineer
Bayer AG

Download Brochure

Full details regarding Cell Series UK: Virtual are available for download in the Conference Brochure